Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis

Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1322-1324. doi: 10.1002/pds.4994. Epub 2020 Mar 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

Grant support